The heterogeneity of cancer endothelium: The relevance of angiogenesis and endothelial progenitor cells in cancer microenvironment.

Autor: Armani G; Division of Medical Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Italy.. Electronic address: giovanna.armani01@universitadipavia.it., Pozzi E; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Pagani A; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Porta C; Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy., Rizzo M; Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy., Cicognini D; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Rovati B; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Moccia F; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Pedrazzoli P; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Ferraris E; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Jazyk: angličtina
Zdroj: Microvascular research [Microvasc Res] 2021 Nov; Vol. 138, pp. 104189. Date of Electronic Publication: 2021 May 29.
DOI: 10.1016/j.mvr.2021.104189
Abstrakt: Tumor-associated vessels constitution is the result of angiogenesis, the hallmark of cancer essential for tumor to develop in dimension and to spread throughout the organism. Tumor endothelium is configured as an active functioning organ capable of determine interaction with the immune response and all the other components of the variegate cancer microenvironment, determining reciprocal influence. Angiogenesis is here analyzed in its molecular and cellular mechanisms, multiple mediators and principal players, represented by Endothelial Cells. It is discussed the striking heterogeneity of cancer endothelium, due to morphological and molecular aberrations that it often presents and its multiple origin. Among the cells that participate to the composition of tumor vasculature, Endothelial Progenitor Cells represent an important source for physical sustain and paracrine signaling in the process of angiogenesis. Treatment options are reviewed, with particular focus on novel therapeutic strategies for overcoming tumor resistance to anti-angiogenic agents.
(Copyright © 2021 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: